Search Results - Clifton‐Hadley, Laura

  • Showing 1 - 20 results of 20
Refine Results
  1. 1
    Dose specification for hippocampal sparing whole brain radiotherapy (HS WBRT): considerations from the UK HIPPO trial QA programme

    Dose specification for hippocampal sparing whole brain radiotherapy (HS WBRT): considerations from the UK HIPPO trial QA programme by Megias, Daniel, Phillips, Mark, Clifton-Hadley, Laura, Harron, Elizabeth, Eaton, David J, Sanghera, Paul, Whitfield, Gillian

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Predicted Risks of Cardiovascular Disease Following Chemotherapy and Radiotherapy in the UK NCRI RAPID Trial of Positron Emission Tomography–Directed Therapy for Early-Stage Hodgkin Lymphoma

    Predicted Risks of Cardiovascular Disease Following Chemotherapy and Radiotherapy in the UK NCRI RAPID Trial of Positron Emission Tomography–Directed Therapy for Early-Stage Hodgki... by Cutter, David J., Ramroth, Johanna, Diez, Patricia, Buckle, Andy, Ntentas, Georgios, Popova, Bilyana, Clifton-Hadley, Laura, Hoskin, Peter J., Darby, Sarah C., Radford, John, Illidge, Tim

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Whole-body MRI for staging and interim response monitoring in paediatric and adolescent Hodgkin’s lymphoma: a comparison with multi-modality reference standard including (18)F-FDG-PET-CT

    Whole-body MRI for staging and interim response monitoring in paediatric and adolescent Hodgkin’s lymphoma: a comparison with multi-modality reference standard including (18)F-FDG-... by Latifoltojar, Arash, Punwani, Shonit, Lopes, Andre, Humphries, Paul D., Klusmann, Maria, Menezes, Leon Jonathan, Daw, Stephen, Shankar, Ananth, Neriman, Deena, Fitzke, Heather, Clifton-Hadley, Laura, Smith, Paul, Taylor, Stuart A.

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Treatment of classical Hodgkin lymphoma in young adults aged 18–30 years with a modified paediatric Hodgkin lymphoma protocol. Results of a multicentre phase II clinical trial (CRUK/08/012)

    Treatment of classical Hodgkin lymphoma in young adults aged 18–30 years with a modified paediatric Hodgkin lymphoma protocol. Results of a multicentre phase II clinical trial (CRU... by Townsend, William, Leong, Sarah, Hoskin, Peter, Diez, Patricia, Patrick, Pip, Linch, David, Wong, Wai‐Lup, Kayani, Irfan, Sanghera, Bal, Lopes, Andre, Daw, Stephen, Collins, Graham, Clifton‐Hadley, Laura, Ardeshna, Kirit

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    Multi-Center Randomized Phase II Study Comparing Cediranib plus Gefitinib with Cediranib plus Placebo in Subjects with Recurrent/Progressive Glioblastoma

    Multi-Center Randomized Phase II Study Comparing Cediranib plus Gefitinib with Cediranib plus Placebo in Subjects with Recurrent/Progressive Glioblastoma by Brown, Nicholas, McBain, Catherine, Nash, Stephen, Hopkins, Kirsten, Sanghera, Paul, Saran, Frank, Phillips, Mark, Dungey, Fiona, Clifton-Hadley, Laura, Wanek, Katharina, Krell, Daniel, Jeffries, Sarah, Khan, Iftekhar, Smith, Paul, Mulholland, Paul

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Maximum tumor diameter is associated with event-free survival in PET-negative patients with stage I/IIA Hodgkin lymphoma

    Maximum tumor diameter is associated with event-free survival in PET-negative patients with stage I/IIA Hodgkin lymphoma by Illidge, Tim M., Phillips, Elizabeth H., Counsell, Nicholas, Pettengell, Ruth, Johnson, Peter W. M., Culligan, Dominic J., Popova, Bilyana, Clifton-Hadley, Laura, McMillan, Andrew, Hoskin, Peter, Barrington, Sally F., Radford, John

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    Favourable outcomes for high‐risk Burkitt lymphoma patients (IPI 3‐5) treated with rituximab plus CODOX‐M/IVAC: Results of a phase 2 UK NCRI trial

    Favourable outcomes for high‐risk Burkitt lymphoma patients (IPI 3‐5) treated with rituximab plus CODOX‐M/IVAC: Results of a phase 2 UK NCRI trial by Phillips, Elizabeth H., Burton, Catherine, Kirkwood, Amy A., Barrans, Sharon, Lawrie, Anthony, Rule, Simon, Patmore, Russell, Pettengell, Ruth, Ardeshna, Kirit M., Montoto, Silvia, Paneesha, Shankara, Clifton‐Hadley, Laura, Linch, David C., McMillan, Andrew K.

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    Determinants of ovarian function after response-adapted therapy in patients with advanced Hodgkin's lymphoma (RATHL): a secondary analysis of a randomised phase 3 trial

    Determinants of ovarian function after response-adapted therapy in patients with advanced Hodgkin's lymphoma (RATHL): a secondary analysis of a randomised phase 3 trial by Anderson, Richard A, Remedios, Rachel, Kirkwood, Amy A, Patrick, Pip, Stevens, Linsey, Clifton-Hadley, Laura, Roberts, Tom, Hatton, Chris, Kalakonda, Nagesh, Milligan, Don W, McKay, Pam, Rowntree, Clare, Scott, Fiona M, Johnson, Peter W M

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    Positron Emission Tomography Score Has Greater Prognostic Significance Than Pretreatment Risk Stratification in Early-Stage Hodgkin Lymphoma in the UK RAPID Study

    Positron Emission Tomography Score Has Greater Prognostic Significance Than Pretreatment Risk Stratification in Early-Stage Hodgkin Lymphoma in the UK RAPID Study by Barrington, Sally F., Phillips, Elizabeth H., Counsell, Nicholas, Hancock, Barry, Pettengell, Ruth, Johnson, Peter, Townsend, William, Culligan, Dominic, Popova, Bilyana, Clifton-Hadley, Laura, McMillan, Andrew, Hoskin, Peter, O’Doherty, Michael J., Illidge, Tim, Radford, John

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    Hydroxychloroquine and short-course radiotherapy in elderly patients with newly diagnosed high-grade glioma: a randomized phase II trial

    Hydroxychloroquine and short-course radiotherapy in elderly patients with newly diagnosed high-grade glioma: a randomized phase II trial by Brazil, Lucy, Swampillai, Angela L, Mak, Ka Man, Edwards, Darren, Mesiri, Pavlina, Clifton-Hadley, Laura, Shaffer, Richard, Lewis, Joanne, Watts, Colin, Jeffries, Sarah, Gkogkou, Pinelopi, Chalmers, Anthony J, Fersht, Naomi L, Hackshaw, Allan, Short, Susan C

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    COVID‐19 and myeloma clinical research – experience from the CARDAMON clinical trial

    COVID‐19 and myeloma clinical research – experience from the CARDAMON clinical trial by Camilleri, Marquita, Sive, Jonathan, Wilson, William, Pang, Gavin, Jenner, Richard, Phillips, Elizabeth, Popat, Rakesh, Ramasamy, Karthik, Bygrave, Ceri, Dadaga, Tushhar, Streetly, Matthew, Cavenagh, James, Chapman, Mike, Barrington, Sally, Pike, Lucy, Owen, Roger, Clifton‐Hadley, Laura, Yong, Kwee

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  12. 12
    Primary graft failure, but not relapse, may be identified by early chimerism following double cord blood unit transplantation

    Primary graft failure, but not relapse, may be identified by early chimerism following double cord blood unit transplantation by Hough, Rachael, Lopes, Andre, Patrick, Pip, Russell, Nigel, Raj, Kavita, Tholouli, Eleni, A. Snowden, John, Collin, Matthew, El-Mehidi, Nadjet, Lawrie, Anthony, Clifton-Hadley, Laura, Veys, Paul, Craddock, Charles, Mackinnon, Stephen, Cook, Gordon, Shaw, Bronwen, Marks, David

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  13. 13
    Allo-HSCT in transplant-naïve patients with Hodgkin lymphoma: a single-arm, multicenter study

    Allo-HSCT in transplant-naïve patients with Hodgkin lymphoma: a single-arm, multicenter study by Das-Gupta, Emma, Thomson, Kirsty J., Bloor, Adrian J. C., Clark, Andrew D., Mackinnon, Stephen, Kayani, Irfan, Clifton-Hadley, Laura, Patrick, Pip, El-Mehidi, Nadjet, Lawrie, Anthony, Kirkwood, Amy A., Russell, Nigel H., Linch, David C., Peggs, Karl S.

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  14. 14
    In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission: results from the prospective, single-arm evaluation of the UKALL14 trial

    In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission: result... by Marks, David I, Clifton-Hadley, Laura, Copland, Mhairi, Hussain, Jiaull, Menne, Tobias F, McMillan, Andrew, Moorman, Anthony V, Morley, Nicholas, Okasha, Dina, Patel, Bela, Patrick, Pip, Potter, Michael N, Rowntree, Clare J, Kirkwood, Amy A, Fielding, Adele K

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  15. 15
    An Evaluation of the Tolerability and Feasibility of Combining 5-Amino-Levulinic Acid (5-ALA) with BCNU Wafers in the Surgical Management of Primary Glioblastoma

    An Evaluation of the Tolerability and Feasibility of Combining 5-Amino-Levulinic Acid (5-ALA) with BCNU Wafers in the Surgical Management of Primary Glioblastoma by Watts, Colin, Ashkan, Keyoumars, Jenkinson, Michael D., Price, Stephen J., Santarius, Thomas, Matys, Tomasz, Zhang, Ting Ting, Finch, Alina, Collins, Peter, Allinson, Kieren, Jefferies, Sarah J., Scoffings, Daniel J., Zisakis, Athanasios, Phillips, Mark, Wanek, Katharina, Smith, Paul, Clifton-Hadley, Laura, Counsell, Nicholas

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  16. 16
    IKZF1 alterations are not associated with outcome in 498 adults with B-precursor ALL enrolled in the UKALL14 trial

    IKZF1 alterations are not associated with outcome in 498 adults with B-precursor ALL enrolled in the UKALL14 trial by Mitchell, Rachel J., Kirkwood, Amy A., Barretta, Emilio, Clifton-Hadley, Laura, Lawrie, Emma, Lee, SooWah, Leongamornlert, Daniel, Marks, David I., McMillan, Andrew K., Menne, Tobias F., Papaemmanuil, Elli, Patel, Bela, Patrick, Pip, Rowntree, Clare J., Zareian, Nahid, Alapi, Krisztina Zuborne, Moorman, Anthony V., Fielding, Adele K.

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  17. 17
    Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study

    Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study by Moorman, Anthony V., Barretta, Emilio, Butler, Ellie R., Ward, Eleanor J., Twentyman, Katie, Kirkwood, Amy A., Enshaei, Amir, Schwab, Claire, Creasey, Tom, Leongamornlert, Daniel, Papaemmanuil, Elli, Patrick, Pip, Clifton-Hadley, Laura, Patel, Bela, Menne, Tobias, McMillan, Andrew K., Harrison, Christine J., Rowntree, Clare J., Marks, David I., Fielding, Adele K.

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  18. 18
    Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia

    Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia by Roddie, Claire, Dias, Juliana, O'Reilly, Maeve A., Abbasian, Mahnaz, Cadinanos-Garai, Amaia, Vispute, Ketki, Bosshard-Carter, Leticia, Mitsikakou, Marina, Mehra, Vedika, Roddy, Harriet, Hartley, John A., Spanswick, Victoria, Lowe, Helen, Popova, Bilyana, Clifton-Hadley, Laura, Wheeler, Graham, Olejnik, Joanna, Bloor, Adrian, Irvine, David, Wood, Leigh, Marzolini, Maria A. V., Domning, Sabine, Farzaneh, Farzin, Lowdell, Mark W., Linch, David C., Pule, Martin A., Peggs, Karl S.

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  19. 19
    RNA-seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature

    RNA-seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature by Chapman, Michael A., Sive, Jonathan, Ambrose, John, Roddie, Claire, Counsell, Nicholas, Lach, Anna, Abbasian, Mahnaz, Popat, Rakesh, Cavenagh, Jamie D., Oakervee, Heather, Streetly, Matthew J., Schey, Stephen, Koh, Mickey, Willis, Fenella, Virchis, Andres E., Crowe, Josephine, Quinn, Michael F., Cook, Gordon, Crawley, Charles R., Pratt, Guy, Cook, Mark, Braganza, Nivette, Adedayo, Toyin, Smith, Paul, Clifton-Hadley, Laura, Owen, Roger G., Sonneveld, Pieter, Keats, Jonathan J., Herrero, Javier, Yong, Kwee

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  20. 20
    Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, randomised controlled trial

    Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, rand... by Marks, David I, Kirkwood, Amy A, Rowntree, Clare J, Aguiar, Melanie, Bailey, Katharine E, Beaton, Brendan, Cahalin, Paul, Castleton, Anna Z, Clifton-Hadley, Laura, Copland, Mhairi, Goldstone, Anthony H, Kelly, Richard, Lawrie, Emma, Lee, SooWah, McMillan, Andrew K, McMullin, Mary Frances, Menne, Tobias F, Mitchell, Rachel J, Moorman, Anthony V, Patel, Bela, Patrick, Pip, Smith, Paul, Taussig, David, Yallop, Deborah, Alapi, Krisztina Zuborne, Fielding, Adele K

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: